Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
Oncogene
|
April 19, 2022
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Max A K Rätze, Thijs Koorman, Thijmen Sijnesael, et al.
Cancer Treatment Reviews
|
June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
Carlotta Becherini, Luca Visani, Saverio Caini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
The Journal of Clinical Investigation
|
February 22, 2022
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Angela M Araujo, Andrea Abaurrea, Peio Azcoaga, et al.
Cancer Research
|
February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L Flaherty, Flavia Hughes, George Sflomos, et al.
Blood
|
February 21, 2009
A HaemAtlas: characterizing gene expression in differentiated human blood cells
Nicholas A Watkins, Arief Gusnanto, Bernard de Bono, et al.
Nature
|
February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolution
Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
Oncogene
|
April 19, 2022
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Max A K Rätze, Thijs Koorman, Thijmen Sijnesael, et al.
Cancer Treatment Reviews
|
June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
Carlotta Becherini, Luca Visani, Saverio Caini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
The Journal of Clinical Investigation
|
February 22, 2022
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Angela M Araujo, Andrea Abaurrea, Peio Azcoaga, et al.
Cancer Research
|
February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L Flaherty, Flavia Hughes, George Sflomos, et al.
Blood
|
February 21, 2009
A HaemAtlas: characterizing gene expression in differentiated human blood cells
Nicholas A Watkins, Arief Gusnanto, Bernard de Bono, et al.
Nature
|
February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolution
Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Page
of 10